Address
Block 35, Mereside
Alderley Park
Alderley Edge
Cheshire, SK10 4TG
United Kingdom
Contact
Beverley Isherwood+447548961848
beverley.isherwood@md.catapult.org.uk
Website
Empowering Innovation: Accelerating Translation
We bring together the sector to help innovators with early-stage antimicrobial and diagnostic projects move forward with greater speed and confidence, accelerating the delivery of new innovations to tackle AMR.
PACE aims to offer a collaborative approach to project development and delivery. We will support PACE awardees to align their AMR asset with the right translational roadmap and ensure supporting data packages are appropriately targeted and strengthened. PACE awardees will also benefit from a network of potential delivery partners, advisors and mentors to help them develop their AMR assets at pace.
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Viruses
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
- Institute
- Company
- Academia
- NGO
- Government
Partnering:
- Co-develop
- License
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- BSI
- RTI
- IAI
- STI
- GII
- SSTI
- CNSI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
We are looking for innovators, delivery partners and strategic partners to help us create and support a new early pipeline
PACE (Pathways to Antimicrobial Clinical Efficacy) is a £30 million initiative supporting early-stage innovation in medicines and diagnostics to tackle AMR. It is a collaboration between Innovate UK, LifeArc, and Medicines Discovery Catapult and aims to work with the global AMR community to accelerate the speed of innovation to mitigate the risk of AMR.
PACE is looking to connect with the community to identify and support portfolio projects with the most transformative potential in tackling AMR.
